Longitudinal Health Optimization

Quant Biomarkers is a Swiss longevity technology company focused on personalised biomarker panels and new targeted interventions for chronic diseases and ageing

Company Goals

Quant Biomarkers' primary mission is to advance biomarker technologies, predict risks for the onset of chronic diseases to identify targets for personalized medical interventions

We target biology of aging as our foundation for disease prevention

QuantBio combines longitudinal clinical, health records & wellness data to evaluate multiple dimensions of aging. We complement this data with virtual tissue modelling and Artificial Intelligence, to tangibly improve the quality of an individual's lifespan

Quant.png

Who we are

Quant Biomarkers is a data-driven biotechnology company that specialises in quantitative assessment of biomarkers of human longevity and in development of personalised biomarker panels as early targets for interventions in aging diseases

Vision

Develop practical applications of biomarker panels to enable the delivery of personalised and precision medical management

123.jpg
4.png

Mission

Disrupt the current healthcare system by advancing new biomarker technologies for early detection of health decay leading to disease, and introduction of preventive care interventions

 

Unlock the biology of aging for individuals personalized care to avoid disorders at early ages and improve quality of life at older age

Objective

We work with high-quality longitudinal human data and medical records that enable us to correlate our biological measurements with health outcomes. We use Proprietary Virtual Cell technology to determine which pathways are most strongly associated with diseases onset and identify critical intervention targets for healthy longevity

 

We develop tools that guide and empower medical decision-making, by all the stakeholders in the patient ecosystem

5.png
Untitled design.jpg

Our company strategic imperative:

Quant Biomarker’s focus is to drive for sustainable, preventive, and scalable digital health solutions for Healthy Lifespan

 

Our strategic direction is in developing personalised biomarker panels for aging related chronic diseases and selection of endpoints for interventions and multitreatment modalities

9.jpg

Our Deliverables

Proprietary products:

  • AI-based Algorithms for disease risk predictions and early interventions

  • Personalized medical intervention protocols

  • Tissue-specific Biomarker Panels for diagnostic use

  • New Biomarker IP for therapeutics

  • Digital Twin consumer application for Real-Time Data exchange & timely Interventions

Partners

Screenshot 2022-08-26 at 3.59.34 PM.png
Screenshot 2022-08-26 at 3.59.40 PM.png
BioFi.png
Praxis (1).png
white_logo_color_background.jpg
Untitled design (1).png
Basel-Area-CMYK-logo.jpeg
grit.jpg